RNA5SP242: A Potential Drug Target and Biomarker (G100873500)

Target Name: RNA5SP242

NCBI ID: G100873500

RNA5SP242

Other Name(s): RNA, 5S ribosomal pseudogene 242 | RN5S242

RNA5SP242: A Potential Drug Target and Biomarker

RNA5SP242 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell鈥檚 immune response and has been shown to play a critical role in the regulation of inflammation and cellular processes that are important for the development and progression of various diseases.

The discovery of RNA5SP242

RNA5SP242 was identified through a combination of computational screening and experimental validation. Researchers used a variety of techniques to identify potential binding partners of RNA5SP242, including RNA-protein interactions, ChIP-Seq assays, and RNA sequencing. They found that RNA5SP242 interacted strongly with a protein called FAK, which is known to be a critical regulator of cell-cell adhesion and a key driver of cancer progression.

Further experiments revealed that RNA5SP242 was highly expressed in a variety of human tissues and that it was highly enriched in the bloodstream. These findings suggested that RNA5SP242 may be a promising biomarker for cancer and other diseases.

The potential functions of RNA5SP242

RNA5SP242 has been shown to play a critical role in the regulation of cellular processes that are important for the development and progression of various diseases. One of its most well-studied functions is its role in the regulation of cell-cell adhesion. RNA5SP242 has been shown to interact with a protein called FAK, which is known to be a critical regulator of cell-cell adhesion and a key driver of cancer progression.

In addition to its role in cell-cell adhesion, RNA5SP242 has also been shown to play a critical role in the regulation of inflammation and cellular processes that are important for the development and progression of various diseases. For example, RNA5SP242 has been shown to be highly expressed in the inflammatory tissues and to play a role in the regulation of inflammation-related processes.

The potential uses of RNA5SP242 as a drug target

The potential uses of RNA5SP242 as a drug target are vast and varied. RNA5SP242 has been shown to play a critical role in the regulation of cell-cell adhesion, which is important for the development and progression of various diseases. As such, RNA5SP242 may be an effective target for drugs that are designed to modulate cell-cell adhesion.

In addition to its role in cell-cell adhesion, RNA5SP242 has also been shown to play a critical role in the regulation of inflammation and cellular processes that are important for the development and progression of various diseases. As such, RNA5SP242 may be an effective target for drugs that are designed to modulate inflammation and cellular processes.

The potential applications of RNA5SP242 as a biomarker

The potential applications of RNA5SP242 as a biomarker are also vast and varied. RNA5SP242 has been shown to be highly expressed in a variety of human tissues and has been shown to be highly enriched in the bloodstream. As such, RNA5SP242 may be an effective biomarker for a variety of diseases, including cancer.

In addition to its potential as a drug target, RNA5SP242 has also been shown to have potential as a biomarker. Its high expression and enrichment in the bloodstream make it an promising candidate for use as a biomarker for a variety of diseases, including cancer.

Conclusion

RNA5SP242 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It has been shown to play a critical role in the regulation of cell

Protein Name: RNA, 5S Ribosomal Pseudogene 242

The "RNA5SP242 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA5SP242 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets